# A Phase I Clinical Study of VSA012 in Healthy Volunteers

> **NCT06766929** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Bisirna Therapeutics (Suzhou) Co., Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** VSA012
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06766929
- **Lead sponsor:** Bisirna Therapeutics (Suzhou) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-01-20
- **Primary completion:** 2026-08
- **Final completion:** 2027-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06766929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06766929, "A Phase I Clinical Study of VSA012 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06766929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*